Palisade Bio (PALI) Financials

$2.09

$0.05 (2.20%)

As on 04-Sep-2026 16:00EDT

Market cap

$364 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

3.2

P/B Ratio

2.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.50	--	--	0.25	0.25	--
Cost of Revenue	--	0.00	0.00	0.00	0.17	0.17
Gross Profit	0.50	0.00	0.00	0.25	-0.17	-0.17
Operating Expenses	35.85	18.06	14.86	13.32	15.72	41.85
Operating Profit (EBIT)	-35.35	-18.06	-14.86	-13.07	-15.72	-41.85
Other Income	--	--	--	--	--	--
Profit before Tax	-31.94	-16.78	-14.44	-12.30	-14.26	-26.62
Provision for Tax	--	--	--	0.02	-1.46	0.66
Profit after Tax (Net Income)	-31.94	-16.78	-14.44	-12.30	-14.26	-26.62
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-14.55	-26.62

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	121.75	129.38	7.49	11.31	12.48	7.37
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.32	0.33	0.15	0.15	0.27	2.65
Current Liabilities	5.25	4.64	3.24	2.59	3.01	2.50
Total Liabilities	132.56	134.34	10.88	14.05	15.76	12.51

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.06	0.12	0.36	0.72	1.03	1.01
Current Assets	127.26	134.22	10.49	13.33	14.73	11.51
Total Assets	132.56	134.34	10.88	14.05	15.76	12.51
Total Debt*	--	0.07	0.17	0.37	0.40	0.20
Net Current Assets	122.01	129.59	7.26	10.74	11.72	9.88

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-10.85	-12.19	-11.13	-13.36	-14.77
Cash Flow from Investing Activities	--	--	--	0.00	-0.01	-0.05
Cash from Financing Activities	--	134.44	9.58	11.19	15.26	24.61
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.64	-0.30	-1.69	-1.33	-7.91	-98.32
Cash EPS ($)	0.66	-0.30	-1.69	-1.33	-7.91	-98.32
Adjusted Book Value ($)	0.70	2.32	0.88	1.22	6.92	27.21
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.19	-1.43	-1.20	-7.41	-54.57
Free Cash Flow per Share ($)	--	-0.19	-1.43	-1.20	-7.42	-54.57

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-24.48	-149.28	-100.14	-139.48	-2,822.48
ROE (%)	-25.44	-24.52	-153.55	-103.40	-143.72	-20,012.03
ROA (%)	-44.61	-23.11	-115.82	-82.51	-100.87	-342.75
EBIT Margin (%)	-2,609.00	--	--	-4,914.00	-5,698.80	--
Net Margin (%)	-6,388.20	--	--	-4,920.00	-5,704.00	--
Cash Profit Margin (%)	-6.39	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	12,400.00	--	-1.00	--	--	-1.00
EBIT Growth (%)	-10.27	-16.26	-17.43	13.77	41.17	-140.09
Net Profit Growth (%)	-169.66	-16.23	-17.38	13.74	46.42	-157.86
EPS Growth (%)	68.60	0.82	-0.27	0.83	0.92	-1.26
Book Value Growth (%)	5.46	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	3.17	-7.80	-0.98	-0.44	-0.66	-0.01
Price / Book Value	2.81	1.01	1.88	0.48	0.75	0.05
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.57	0.15	-0.31	0.54	0.18	0.41
Close Price ($)	2.09	2.35	1.65	0.59	5.20	65.00
High Price ($)	2.86	2.64	9.65	8.54	81.00	801.00
Low Price ($)	0.53	0.53	0.36	0.50	1.74	65.00
Market Cap ($ Cr)	364.23	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.02	0.03	0.03	0.03
Short term debt to equity ratio	--	0.00	0.02	0.02	0.02	0.03
Current Ratio	24.26	28.95	3.24	5.15	4.89	4.61
Quick Ratio	24.26	--	3.24	--	5.37	4.67
Interest Coverage	-3,991.63	-1,677.10	-1,202.17	-819.00	-1,095.92	-10.10

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	100.00	--	--	59.20	575.20	--
Asset Turnover	0.01	--	--	0.02	0.02	--
Receivable days	--	--	--	1,158.57	1,160.03	--
Inventory Days	--	1,461.00	1,461.00	-131,307.38	-1,736.58	-2,584.53
Payable days	--	120,593.38	116,393.00	112,177.41	3,583.61	4,408.00
Cash Conversion Cycle	--	--	--	-242,326.21	-4,160.15	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.